NanoLogix, Inc. (NNLX)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Dec 31, 2025
NanoLogix Company Description
NanoLogix, Inc., a biotechnology company, provides diagnostics of viable microorganisms and viruses.
It offers rapid viral assay test, which is a method for detection and quantification of a virus; and N-assay diagnostics that furnish the ability to detect and identify bacteria and other microorganisms for pharmaceutical, industrial, veterinary, and environmental testing, as well as microbiology, soil microbiology and bioremediation, microbial physiology, pharmacology, pharmaco-kinetics, and antibiotic sensitivity sectors.
The company sells its products to established medical and scientific entities, including laboratories, medical institutions, universities, businesses, and research establishments.
NanoLogix, Inc. is based in Hubbard, Ohio.
NanoLogix, Inc.

| Country | United States |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 7 |
| CEO | Bret Barnhizer |
Contact Details
Address: 843 North Main Street Hubbard, Ohio 44425 United States | |
| Phone | 330-534-0800 |
| Website | nanologix.com |
Stock Details
| Ticker Symbol | NNLX |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US6300761078 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Bret T. Barnhizer | Chairman, Chief Executive Officer and President |
| Carol J. Surrena | Corporate Secretary |